{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:15:57Z","timestamp":1780330557226,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006378","name":"Universitas Indonesia","doi-asserted-by":"publisher","award":["BA-601\/UN2.RST\/PPM.00.03.01\/2021"],"award-info":[{"award-number":["BA-601\/UN2.RST\/PPM.00.03.01\/2021"]}],"id":[{"id":"10.13039\/501100006378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>EBV infection in nasopharyngeal cancer ensued in latent infection mode. In this latent infection various EBV oncoproteins such as EBNA1 and LMP1 was expressed. EBV oncoproteins could theoretically recruit immune cells, which might help to control cancer. Therefore, this study was aimed to elucidate the association with EBV oncoproteins (EBNA1 and LMP1), immune markers (CD4, CD8, and FOXP3) from nasopharyngeal cancer microenvironment with tumor progression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Nasopharyngeal biopsy was obtained from patients suspected to have nasopharyngeal cancer. Those samples with microscopically confirmed nasopharyngeal cancer were tested for EBNA1, LMP1, CD4, CD8, and FOXP3 concentration with ELISA, then verified with IHC. Each patient tumor volume was assessed for primary nasopharyngeal tumor volume (GTVp) and neck nodal metastases tumor volume (GTVn). Correlation test with Spearman correlation and scatterplot were carried out.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>Total 23 samples with nasopharyngeal cancer were analyzed. There was moderate correlation (<jats:italic>\u03c1<\/jats:italic>\u2009=\u20090.45; <jats:italic>p<\/jats:italic> value\u2009=\u20090.032) between LMP1 and GTVp. There was strong correlation (<jats:italic>\u03c1<\/jats:italic>\u2009=\u20090.81; <jats:italic>p<\/jats:italic> value\u2009&lt;\u20090.001) between CD8 and GTVp. There was also moderate correlation (<jats:italic>\u03c1<\/jats:italic>\u2009=\u20090.6; <jats:italic>p<\/jats:italic> value\u2009=\u20090.002) between FOXP3 and GTVp. The CD8 concentration has moderate correlation with both EBNA1 (<jats:italic>\u03c1<\/jats:italic>\u2009=\u20090.46; <jats:italic>p<\/jats:italic> value\u2009=\u20090.026) and LMP1 (<jats:italic>\u03c1<\/jats:italic>\u2009=\u20090.47; <jats:italic>p<\/jats:italic> value\u2009=\u20090.023). While FOXP3 has moderate correlation with only LMP1 (<jats:italic>\u03c1<\/jats:italic>\u2009=\u20090.58; <jats:italic>p<\/jats:italic> value\u2009=\u20090.004). No correlation was found between all the markers tested here with GTVn.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>We found larger primary nasopharyngeal tumor was associated with higher CD8 marker. This was thought due to the presence of abundance CD8 T cells in the nasopharynx, but those abundance CD8 T cells were suspected to be dysfunctional. The nasopharyngeal cancer was also known to upregulate chemokines that could recruit T regulatory FOXP3 cells. Furthermore, T regulatory FOXP3 cells differentiation was induced through several pathways which was triggered by EBNA1. The correlation found in this study could guide further study to understand nasopharyngeal carcinogenesis and the relationship with our immune system.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-022-09948-9","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T07:15:54Z","timestamp":1660374954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immune cells markers within local tumor microenvironment are associated with EBV oncoprotein in nasopharyngeal cancer"],"prefix":"10.1186","volume":"22","author":[{"given":"Soehartati A.","family":"Gondhowiardjo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlinda","family":"Adham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisnawati","family":"Rachmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tubagus Djumhana","family":"Atmakusuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demak Lumban","family":"Tobing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesa","family":"Auzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustinus Darmadi","family":"Hariyanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dede","family":"Sulaeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiara Bunga Mayang","family":"Permata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Handoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,13]]},"reference":[{"issue":"10192","key":"9948_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"Y-P Chen","year":"2019","unstructured":"Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet (London, England). 2019;394(10192):64\u201380.","journal-title":"Lancet (London, England)"},{"key":"9948_CR2","doi-asserted-by":"crossref","unstructured":"Gondhowiardjo SA, Adham M, Lisnawati L, et al. Current Immune-Related Molecular Approach in Combating Nasopharyngeal Cancer. World J Oncol Vol 10, No 4\u20135, Oct 2019. 2019 Sep;","DOI":"10.14740\/wjon1214"},{"key":"9948_CR3","doi-asserted-by":"crossref","unstructured":"Gondhowiardjo S, Muthalib A, Khotimah S, Rachman A. Nimotuzumab combined with radiotherapy reduces primary tumor and nodal volume in advanced undifferentiated nasopharyngeal carcinoma. Vol. 5, Asia-Pacific Journal of Clinical Oncology. 2009. p. 175.","DOI":"10.1111\/j.1743-7563.2009.01227.x"},{"key":"9948_CR4","doi-asserted-by":"crossref","unstructured":"Gondhowiardjo SA, Handoko, Adham M, et al. Epstein\u2013Barr Virus (EBV) Viral Load in Tumor Cells Did Not Predict Tumor Extensiveness in Nasopharyngeal Cancer. Microbiol Res (Pavia). 2021;12(1):150\u20136.","DOI":"10.3390\/microbiolres12010011"},{"key":"9948_CR5","doi-asserted-by":"crossref","unstructured":"Gondhowiardjo SA, Handoko, Adham M, et al. Tumor microenvironment predicts local tumor extensiveness in PD-L1 positive nasopharyngeal cancer. PLoS One. 2020;15(3):e0230449.","DOI":"10.1371\/journal.pone.0230449"},{"issue":"6","key":"9948_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa1701717","volume":"377","author":"KCA Chan","year":"2017","unstructured":"Chan KCA, Woo JKS, King A, et al. Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer. N Engl J Med. 2017;377(6):513\u201322.","journal-title":"N Engl J Med"},{"key":"9948_CR7","doi-asserted-by":"crossref","unstructured":"Adham M, Greijer AE, Verkuijlen SAWM, et al. Epstein-Barr Virus DNA Load in Nasopharyngeal Brushings and Whole Blood in Nasopharyngeal Carcinoma Patients before and after Treatment. Clin Cancer Res. 2013;2175\u201387.","DOI":"10.1158\/1078-0432.CCR-12-2897"},{"issue":"8","key":"9948_CR8","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/hed.26096","volume":"42","author":"C-W Twu","year":"2020","unstructured":"Twu C-W, Wang W-Y, Tsou H-H, et al. Effects of Epstein-Barr virus viral load and different treatment modality for stage III nasopharyngeal carcinoma. Head Neck. 2020;42(8):1765\u201374.","journal-title":"Head Neck"},{"issue":"1","key":"9948_CR9","doi-asserted-by":"publisher","first-page":"15432","DOI":"10.1038\/s41598-019-51767-9","volume":"9","author":"JS Nilsson","year":"2019","unstructured":"Nilsson JS, Forslund O, Andersson FC, Lindstedt M, Greiff L. Intralesional EBV-DNA load as marker of prognosis for nasopharyngeal cancer. Sci Rep. 2019;9(1):15432.","journal-title":"Sci Rep"},{"key":"9948_CR10","doi-asserted-by":"crossref","unstructured":"Richardo T, Prattapong P, Ngernsombat C, et al. Epstein-Barr Virus Mediated Signaling in Nasopharyngeal Carcinoma Carcinogenesis. Cancers (Basel). 2020 Aug;12(9).","DOI":"10.3390\/cancers12092441"},{"issue":"Suppl 2","key":"9948_CR11","first-page":"323","volume":"27","author":"S Gondhowiardjo","year":"2000","unstructured":"Gondhowiardjo S. Epstein-Barr virus latent membrane protein 1 (EBV-LMP1) and tumor proliferation rate as predictive factors of nasopharyngeal cancer (NPC) radiation response. Gan To Kagaku Ryoho. 2000;27(Suppl 2):323\u201331.","journal-title":"Gan To Kagaku Ryoho"},{"key":"9948_CR12","doi-asserted-by":"crossref","unstructured":"Elgui de Oliveira D, Muller-Coan BG, Pagano JS. Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers. Trends Microbiol. 2016 Aug;24(8):649\u201364.","DOI":"10.1016\/j.tim.2016.03.008"},{"issue":"3","key":"9948_CR13","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s12253-019-00777-z","volume":"26","author":"L Sun","year":"2020","unstructured":"Sun L, Wang Y, Shi J, Zhu W, Wang X. Association of Plasma Epstein-Barr Virus LMP1 and EBER1 with Circulating Tumor Cells and the Metastasis of Nasopharyngeal Carcinoma. Pathol Oncol Res. 2020;26(3):1893\u2013901.","journal-title":"Pathol Oncol Res"},{"key":"9948_CR14","doi-asserted-by":"crossref","unstructured":"Gondhowiardjo SA, Handoko, Jayalie VF, et al. Tackling Resistance to Cancer Immunotherapy: What Do We Know? Molecules. 2020 Sep;25(18).","DOI":"10.3390\/molecules25184096"},{"issue":"1","key":"9948_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/jso.25091","volume":"118","author":"K Sideras","year":"2018","unstructured":"Sideras K, Galjart B, Vasaturo A, et al. Prognostic value of intra-tumoral CD8(+) \/FoxP3(+) lymphocyte ratio in patients with resected colorectal cancer liver metastasis. J Surg Oncol. 2018;118(1):68\u201376.","journal-title":"J Surg Oncol"},{"issue":"12","key":"9948_CR16","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1002\/hed.26416","volume":"42","author":"T Ono","year":"2020","unstructured":"Ono T, Azuma K, Kawahara A, et al. Predictive value of CD8\/FOXP3 ratio combined with PD-L1 expression for radiosensitivity in patients with squamous cell carcinoma of the larynx receiving definitive radiation therapy. Head Neck. 2020;42(12):3518\u201330.","journal-title":"Head Neck"},{"issue":"8","key":"9948_CR17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/15384047.2018.1450116","volume":"19","author":"F Li","year":"2018","unstructured":"Li F, Zhao Y, Wei L, Li S, Liu J. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer. Cancer Biol Ther. 2018;19(8):695\u2013705.","journal-title":"Cancer Biol Ther"},{"key":"9948_CR18","doi-asserted-by":"crossref","unstructured":"Darwis NDM, Oike T, Kubo N, Gondhowiardjo SA, Ohno T. Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis. Cancers (Basel). 2020 Aug;12(8).","DOI":"10.3390\/cancers12082180"},{"issue":"4","key":"9948_CR19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3892\/mco.2013.107","volume":"1","author":"M Takenaka","year":"2013","unstructured":"Takenaka M, Seki N, Toh U, et al. FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis. Mol Clin Oncol. 2013;1(4):625\u201332.","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"9948_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/bjd.12641","volume":"170","author":"AL Gerber","year":"2014","unstructured":"Gerber AL, M\u00fcnst A, Schlapbach C, et al. High expression of FOXP3 in primary melanoma is associated with tumour progression. Br J Dermatol. 2014;170(1):103\u20139.","journal-title":"Br J Dermatol"},{"issue":"8","key":"9948_CR21","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1093\/annonc\/mdu191","volume":"25","author":"HR Ali","year":"2014","unstructured":"Ali HR, Provenzano E, Dawson S-J, et al. Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients. Ann Oncol Off J Eur Soc Med Oncol. 2014;25(8):1536\u201343.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"6","key":"9948_CR22","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41416-019-0541-3","volume":"121","author":"K Yoneda","year":"2019","unstructured":"Yoneda K, Kuwata T, Kanayama M, et al. Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer. Br J Cancer. 2019;121(6):490\u20136.","journal-title":"Br J Cancer"},{"issue":"1","key":"9948_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/cam4.1889","volume":"8","author":"S Shimizu","year":"2019","unstructured":"Shimizu S, Hiratsuka H, Koike K, et al. Tumor-infiltrating CD8(+) T-cell density is an independent prognostic marker for oral squamous cell carcinoma. Cancer Med. 2019;8(1):80\u201393.","journal-title":"Cancer Med"},{"issue":"2","key":"9948_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.semcancer.2011.12.002","volume":"22","author":"L Frappier","year":"2012","unstructured":"Frappier L. Role of EBNA1 in NPC tumourigenesis. Semin Cancer Biol. 2012;22(2):154\u201361.","journal-title":"Semin Cancer Biol"},{"key":"9948_CR25","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3389\/fonc.2020.00600","volume":"10","author":"PM Hau","year":"2020","unstructured":"Hau PM, Lung HL, Wu M, et al. Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma. Front Oncol. 2020;10:600.","journal-title":"Front Oncol"},{"issue":"3","key":"9948_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/cncr.28418","volume":"120","author":"L Wang","year":"2014","unstructured":"Wang L, Tian W-D, Xu X, et al. Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells. Cancer. 2014;120(3):363\u201372.","journal-title":"Cancer"},{"key":"9948_CR27","first-page":"119","volume":"391","author":"A Kieser","year":"2015","unstructured":"Kieser A, Sterz KR. The Latent Membrane Protein 1 (LMP1). Curr Top Microbiol Immunol. 2015;391:119\u201349.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"20","key":"9948_CR28","doi-asserted-by":"publisher","first-page":"7663","DOI":"10.1002\/cam4.3357","volume":"9","author":"K Wakae","year":"2020","unstructured":"Wakae K, Kondo S, Pham HT, et al. EBV-LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer. Cancer Med. 2020;9(20):7663\u201371.","journal-title":"Cancer Med"},{"issue":"10","key":"9948_CR29","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.1002\/cam4.1730","volume":"7","author":"M Tsiatas","year":"2018","unstructured":"Tsiatas M, Kalogeras KT, Manousou K, et al. Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy. Cancer Med. 2018;7(10):5066\u201382.","journal-title":"Cancer Med"},{"issue":"11","key":"9948_CR30","first-page":"1","volume":"2","author":"J Li","year":"2007","unstructured":"Li J, Zeng X, Mo H, et al. Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy. PLoS ONE. 2007;2(11):1\u201312.","journal-title":"PLoS ONE"},{"issue":"9","key":"9948_CR31","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1073\/pnas.0813320106","volume":"106","author":"MH Fogg","year":"2009","unstructured":"Fogg MH, Wirth LJ, Posner M, Wang F. Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma. Proc Natl Acad Sci U S A. 2009;106(9):3318\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"9948_CR32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1365-3083.2006.01898.x","volume":"65","author":"MA Rodr\u00edguez-Monroy","year":"2007","unstructured":"Rodr\u00edguez-Monroy MA, Rojas-Hern\u00e1ndez S, Moreno-Fierros L. Phenotypic and functional differences between lymphocytes from NALT and nasal passages of mice. Scand J Immunol. 2007;65(3):276\u201388.","journal-title":"Scand J Immunol"},{"key":"9948_CR33","doi-asserted-by":"crossref","unstructured":"Tsao SW, Tsang CM, Lo KW. Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc London Ser B, Biol Sci. 2017 Oct;372(1732).","DOI":"10.1098\/rstb.2016.0270"},{"key":"9948_CR34","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3389\/fimmu.2019.02193","volume":"10","author":"HM Long","year":"2019","unstructured":"Long HM, Meckiff BJ, Taylor GS. The T-cell Response to Epstein-Barr Virus-New Tricks From an Old Dog. Front Immunol. 2019;10:2193.","journal-title":"Front Immunol"},{"issue":"8","key":"9948_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1005799","volume":"12","author":"HG Woon","year":"2016","unstructured":"Woon HG, Braun A, Li J, et al. Compartmentalization of Total and Virus-Specific Tissue-Resident Memory CD8+ T Cells in Human Lymphoid Organs. PLOS Pathog. 2016;12(8):1\u201319.","journal-title":"PLOS Pathog"},{"key":"9948_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-4598-9-4","volume":"9","author":"Y-L Zhang","year":"2010","unstructured":"Zhang Y-L, Li J, Mo H-Y, et al. Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways. Mol Cancer. 2010;9:4.","journal-title":"Mol Cancer"},{"issue":"15","key":"9948_CR37","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1002\/cam4.3213","volume":"9","author":"J Wang","year":"2020","unstructured":"Wang J, Luo Y, Bi P, et al. Mechanisms of Epstein-Barr virus nuclear antigen 1 favor Tregs accumulation in nasopharyngeal carcinoma. Cancer Med. 2020;9(15):5598\u2013608.","journal-title":"Cancer Med"},{"issue":"5","key":"9948_CR38","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/sj.icb.7100046","volume":"85","author":"S Pai","year":"2007","unstructured":"Pai S, O\u2019Sullivan B, Abdul-Jabbar I, et al. Nasopharyngeal carcinoma-associated Epstein-Barr virus-encoded oncogene latent membrane protein 1 potentiates regulatory T-cell function. Immunol Cell Biol. 2007;85(5):370\u20137.","journal-title":"Immunol Cell Biol"},{"key":"9948_CR39","doi-asserted-by":"crossref","unstructured":"Lo AK-F, Dawson CW, Lung HL, Wong K-L, Young LS. The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy. Front Oncol. 2021;11:262.","DOI":"10.3389\/fonc.2021.640207"},{"key":"9948_CR40","doi-asserted-by":"crossref","unstructured":"Huo S, Luo Y, Deng R, et al. EBV-EBNA1 constructs an immunosuppressive microenvironment for nasopharyngeal carcinoma by promoting the chemoattraction of Treg cells. J Immunother Cancer. 2020;8(2).","DOI":"10.1136\/jitc-2020-001588"},{"issue":"4","key":"9948_CR41","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1159\/000481871","volume":"43","author":"J Ma","year":"2017","unstructured":"Ma J, Xuan S-H, Li Y, Zhang Z-P, Li X-H. Role of the TGF\u03b2\/PDCD4\/AP-1 Signaling Pathway in Nasopharyngeal Carcinoma and Its Relationship to Prognosis. Cell Physiol Biochem. 2017;43(4):1392\u2013401.","journal-title":"Cell Physiol Biochem"},{"issue":"12","key":"9948_CR42","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1111\/cas.13101","volume":"107","author":"R Ogiya","year":"2016","unstructured":"Ogiya R, Niikura N, Kumaki N, et al. Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients. Cancer Sci. 2016;107(12):1730\u20135.","journal-title":"Cancer Sci"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-09948-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-022-09948-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-09948-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T07:17:43Z","timestamp":1660375063000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-022-09948-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,13]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9948"],"URL":"https:\/\/doi.org\/10.1186\/s12885-022-09948-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,13]]},"assertion":[{"value":"27 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants were informed on this research, then written consent were obtained before enrollment to this research. All participants have full right to choose whether to participate or not.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"887"}}